BIOXCEL THERAPEUTICS INC

CUSIP: 09075P105 Class: Common Stock

DAVENPORT & Co LLC's Holding History (CIK: 0000887777)

Note: Option positions (PUT/CALL) are excluded.

Q4 2024
Shares 11,810 Value ($000) $4 Avg Close Range
Q3 2024
Shares 16,855 Value ($000) $10 Avg Close Range
Q2 2024
Shares 21,205 Value ($000) $27 Avg Close Range
Q1 2024
Shares 34,385 Value ($000) $97 Avg Close Range
Q4 2023
Shares 35,385 Value ($000) $104 Avg Close Range
Q3 2023
Shares 61,505 Value ($000) $156 Avg Close Range
Q2 2023
Shares 59,705 Value ($000) $398 Avg Close Range
Q1 2023
Shares 80,295 Value ($000) $1,498 Avg Close Range
Q4 2022
Shares 157,105 Value ($000) $3,375 Avg Close Range
Q3 2022
Shares 108,545 Value ($000) $1,283 Avg Close Range
Q2 2022
Shares 85,670 Value ($000) $1,131 Avg Close Range
Q1 2022
Shares 33,682 Value ($000) $704 Avg Close Range
Q4 2021
Shares 34,682 Value ($000) $705 Avg Close Range
Q3 2021
Shares 22,570 Value ($000) $685 Avg Close Range
Q2 2021
Shares 13,925 Value ($000) $405 Avg Close Range
Q1 2021
Shares 24,150 Value ($000) $1,042 Avg Close Range
Q4 2020
Shares 7,100 Value ($000) $328 Avg Close Range